Joseph Pisegna, MD
Basic profileProfessor of Medicine at UCLA; Chief of the Division of Gastroenterology and Hepatology, VA Greater Los Angeles Healthcare System · VA Greater Los Angeles Healthcare System
Joseph Pisegna is Professor of Medicine at UCLA; Chief of the Division of Gastroenterology and Hepatology, VA Greater Los Angeles Healthcare System at VA Greater Los Angeles Healthcare System. OpenAlex indexes 193 publications with 6,217 citations (h-index 36); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Updated 17 Oct 2026
Joseph Pisegna, MD, is Professor of Medicine at UCLA at University of California, Los Angeles (UCLA). The public record shows 187 publications with 6,246 citations (h-index 36), centered on Neuropeptides and Animal Physiology, Gastrointestinal motility and disorders, Regulation of Appetite and Obesity. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 14 companies, 6 NIH-funded awards (1996–2026).
- Most recent indexed publication: 2025 · The American journal of gastroenterology
- Top research focus: Neuropeptides and Animal Physiology
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 17 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 79.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza
#365,530,420,120
Los Angeles, CA 90095
Telephone
310-794-9718Registry record last updated 8 Jul 2007 · collected 28 Jul 2026.
Clinical trials
Updated 17 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Gastrointestinal Hormonal Regulation of Obesity
Sponsor: VA Office of Research and Development
- Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD
Sponsor: VA Greater Los Angeles Healthcare System
Industry payments
Updated 17 Oct 2026
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Phathom Pharmaceuticals, Inc.Program year202540 payments$33,916openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20257 payments
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Antidiarrheal microorganisms42.9%Creon100%Part D<11 patientsProton pump inhibitor30.6%Dexilant100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 17 Oct 2026
6 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:
- BCCMA: VA Colorectal Cancer Clinical & Computational Collaborative (VA-5C)
Va Greater Los Angeles Healthcare System
FY2026I01BX006367 - CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
Va Greater Los Angeles Healthcare System
FY2022I01BX004560 - CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
Va Greater Los Angeles Healthcare System
FY2021I01BX004560
Congress activity
Updated 17 Oct 2026
1 congress contribution (2019) across ADA per OpenAlex. The most recent:
- 216-LB: Risk Factors of Pancreatic Cancer in Persons with Advancing Diabetes
ADA Scientific Sessions
ADA2019Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 17 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Gastritis: Pathophysiology and Clinical Management.
The American journal of gastroenterology
Article2025 - Diagnosis and Treatment Design Strategy for Gastric Neoplasia.
The American journal of gastroenterology
Comment2023 - β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.
Science translational medicine
Article2021 - Editorial: tegoprazan-the newest advance in the management of acid-related diseases.
Alimentary pharmacology & therapeutics
Comment2020
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.Article446 citations1992
- 04
- 05Alcohol abuse and dependenceArticle269 citations2003
Network
Updated 17 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 17 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joseph-pisegna-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
profiles.ucla.edu/joseph.pisegna
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗ - Other
uclahealth.org/joseph-pisegna
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 17 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- Professor-in-residence
Human Genetics, UCLA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Sarraf, MD
VA Greater Los Angeles Healthcare System
Shelley Shapiro, MD
VA Greater Los Angeles Healthcare System
David Rigberg, MD
VA Greater Los Angeles Healthcare System
Albert Sattin, MD
VA Greater Los Angeles Healthcare System
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”